Femme et Homme
- | Pays :
- Belgium
- United States
- United Kingdom
- | Organes : -
- | Spécialités : -
Extrait
Multi-center, open-label, non-randomized Phase II study to evaluate the efficacy and safety of OSI-7904L in gastric and GEJ cancers. Those patients who do not derive clinical benefit after two cycles may be switched to a commonly used combination regimen.
Critère d'inclusion
- Gastroesophageal Adenocarcinoma ,Gastric Adenocarcinoma